Elite Pharmaceuticals Inc. (ELTP)

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q1 2019 Results - Earnings Call Transcript
Aug. 10, 2018 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q4 2018 Results - Earnings Call Transcript
June 15, 2018 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2018 Results - Earnings Call Transcript
Feb. 12, 2018 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2018 Results - Earnings Call Transcript
Nov. 11, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2018 Results - Earnings Call Transcript
Aug. 12, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2017 Results - Earnings Call Transcript
June 15, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2017 Results - Earnings Call Transcript
Feb. 13, 2017 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2017 Results - Earnings Call Transcript
Nov. 10, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2017 Results - Earnings Call Transcript
Aug. 16, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2016 Results - Earnings Call Transcript
June 20, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2016 Results - Earnings Call Transcript
Feb. 11, 2016 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 Results - Earnings Call Transcript
Nov. 10, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q1 2016 Results - Earnings Call Transcript
Aug. 11, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q4 2015 Results - Earnings Call Transcript
June 16, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 - Earnings Call Transcript
Feb. 18, 2015 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2015 Results - Earnings Call Transcript
Nov. 19, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1FY2015 Results - Earnings Call Transcript
Aug. 18, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2014 Results - Earnings Call Transcript
July 1, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript
Feb. 18, 2014 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals - Q2 2014 Earnings Call Transcript
Nov. 18, 2013 | Price: Free! | Source: Earnings Impact

Elite Pharmaceuticals - Q1 2014 Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Earnings Impact

Elite Pharmaceuticals' CEO Discusses 2Q 2013 Results - Earnings Call Transcript
Aug. 15, 2013 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F4Q2013 Results - Earnings Call Transcript
June 24, 2013 | Price: Free! | Source: Seeking Alpha

Elite Pharmaceuticals' CEO Discusses F3Q13 Results - Earnings Call Transcript
Feb. 19, 2013 | Price: Free! | Source: Seeking Alpha

Recent filings

Elite Pharmaceuticals Files Anda For Codeine And Acetaminophen Combo - Sept. 18, 2018

Elite Pharmaceuticals Files ANDA for Codeine and Acetaminophen Combo - Sept. 18, 2018

Confidential treatment order - Sept. 6, 2018

Financial Statements and - Aug. 30, 2018

Elite Pharmaceuticals Reports Positive Topline Results From A Pivotal Bioequivalence Study - Aug. 14, 2018

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study - Aug. 14, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information - Aug. 9, 2018

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: NOTE 21. SUBSEQUENT ... - Aug. 9, 2018

Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. To Its Board Of Directors - Aug. 7, 2018

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018 - Aug. 7, 2018

Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors - Aug. 7, 2018

Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets - Aug. 6, 2018

Elite Pharmaceuticals Receives Fda Approval For Generic Methadone Hydrochloride Tablets - Aug. 6, 2018

Confidential treatment order - July 19, 2018

Elite Pharmaceuticals Receives Fda Approval For Generic Percocet® Tablets - July 10, 2018

Elite Pharmaceuticals Receives FDA Approval for Generic Percocet® Tablets - July 3, 2018

Elite Pharmaceuticals, Inc. Announces Passing Of Board Member Eugene Pfeifer - June 14, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results For The Fiscal Year Ended March 31, 2018 And Provides Conference Call Information - June 14, 2018

Elite Pharmaceuticals Inc. Just Filed Its Annual Report: NOTE 25. SUBSEQUENT... - June 14, 2018

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer - June 14, 2018

Elite Pharmaceuticals and SunGen Pharma File ANDA for Extended-Release CNS Stimulant - May 30, 2018

Elite Pharmaceuticals And Sungen Pharma File Anda For Extended-Release Cns Stimulant - May 30, 2018

Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA - May 29, 2018

Elite Pharmaceuticals Inc. director just picked up 161,374 shares - Feb. 27, 2018

Elite Pharmaceuticals Inc. director just picked up 161,374 shares - Feb. 27, 2018

CFO of Elite Pharmaceuticals Inc. just picked up 242,060 shares - Feb. 27, 2018

Elite Pharmaceuticals Inc.'s SVP of Operations just picked up 201,717 shares - Feb. 27, 2018

Elite Pharmaceuticals Inc. director just picked up 161,374 shares - Feb. 27, 2018

Elite Pharmaceuticals Inc. director just picked up 161,374 shares - Feb. 27, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017 - Feb. 9, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter Of Fiscal Year 2018 - Feb. 9, 2018

Elite Pharmaceuticals and SunGen Pharma File ANDA - Feb. 8, 2018

Elite Pharmaceuticals And Sungen Pharma File Anda - Feb. 8, 2018

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018 - Feb. 7, 2018

Elite Pharmaceuticals Reports Positive Topline Results From Sequestox™ Pilot Study - Jan. 31, 2018

Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic - Jan. 10, 2018

Elite Pharmaceuticals Reports Positive Topline Results From Pivotal Bioequivalence Studies For An Extended-Release Generic - Jan. 10, 2018

Elite Pharmaceuticals Announces Fda Approval Of Phendimetrazine Tartrate Tablets Usp - Jan. 2, 2018

Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP - Jan. 2, 2018

On December - Dec. 19, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2018 - Nov. 9, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: NOTE 22. SUBSEQUE... - Nov. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017 - Nov. 9, 2017

CORRECTING and REPLACING – Elite Pharmaceuticals, Inc. - Nov. 7, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017 - Nov. 7, 2017

Confidential treatment order - Oct. 11, 2017

Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release - Sept. 20, 2017

Caution Concerning Forward Looking - Sept. 7, 2017

Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference - Aug. 30, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information - Aug. 9, 2017

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: The following i... - Aug. 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2018 Ended June 30, 2017 And Provides Conference Call Information - Aug. 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss First Quarter Financial Results on August 10, 2017 - Aug. 8, 2017

Elite Pharmaceuticals: Elite Announces Co-Development Of Four Additional Products With Sungen Pharma - July 28, 2017

Elite Announces Co-Development of Four Additional Products with SunGen Pharma - July 28, 2017

Elite Pharmaceuticals: Elite Announces New Development And License Agreement With Sungen Pharma Llc - July 12, 2017

Confidential treatment order - July 12, 2017

Elite Announces New Development and License Agreement with SunGen Pharma LLC - July 12, 2017

Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™ - July 7, 2017

Elite Pharmaceuticals Reports Topline Results From A Pivotal Fed Bioequivalence Study For Sequestox™ - July 7, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information - June 14, 2017

Elite Pharmaceuticals Inc. Just Filed Its Annual Report: Earnings (Loss) P... - June 14, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information - June 14, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results on June 15, 2017 - June 13, 2017

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 5, 2017

Elite Pharmaceuticals Inc. Just Received a Notice of Effectiveness - June 5, 2017

Registration statement under Securities Act of 1933 - June 2, 2017

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology - May 31, 2017

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July - May 25, 2017

Elite Pharmaceuticals Acquires Trimipramine Anda - May 22, 2017

Elite Pharmaceuticals Acquires Trimipramine ANDA - May 22, 2017

Notice of Exempt Offering of Securities, item 06b - May 10, 2017

Registration statement under Securities Act of 1933 - May 10, 2017

Major owner of Elite Pharmaceuticals Inc. just disposed of 158,017,321 shares - May 3, 2017

Entry into a Material Definitive - May 2, 2017

Entry into a Material Definitive - May 1, 2017

Entry into a Material Definitive - April 28, 2017

Elite Pharmaceuticals Files ANDA for Pain Product - April 4, 2017

Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study for Reformulated SequestOx™ - March 13, 2017

Elite Pharmaceuticals Inc. director just picked up 68,518 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 72,040 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc.'s SVP of Operations just picked up 110,849 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 88,679 shares - Feb. 27, 2017

Major owner of Elite Pharmaceuticals Inc. just picked up 2,216,992 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 133,019 shares - Feb. 27, 2017

Elite Pharmaceuticals Inc. director just picked up 88,679 shares - Feb. 27, 2017

Elite Pharmaceuticals, Inc. Reports Results For Third Quarter Of Fiscal Year 2017 - Feb. 9, 2017

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 9, 2017

Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017 - Feb. 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017 - Feb. 7, 2017

Elite Reports On SequestOx™ FDA End-of-Review Meeting - Jan. 23, 2017

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study for a Generic OxyContin® - Jan. 17, 2017

Elite Pharmaceuticals: Elite Provides Update On Sequestox™ New Drug Application - Dec. 22, 2016

Confidential treatment order - Dec. 22, 2016

Elite Provides Update on SequestOx™ New Drug Application - Dec. 22, 2016

Elite Pharmaceuticals Files ANDA for Hydrocodone and Acetaminophen Combo - Dec. 12, 2016

Elite Pharmaceuticals: As Of Close Of Business On - Nov. 17, 2016

Elite Pharmaceuticals, Inc. And Subsidiaries PART II – OTHER INFORMATION - Nov. 17, 2016

Elite Pharmaceuticals Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 9, 2016

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: Earnings (Loss) P... - Nov. 9, 2016

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. GENEVA INVESTMENT MANAGEMENT OF CHICAGO LLC 401,252 N/A June 30, 2017
2. Highlander Capital Management, LLC 50,000 N/A June 30, 2018

Elite Pharmaceuticals Inc. (ELTP)

140

cctranscripts

today

Elite Pharmaceuticals Files ANDA for Codeine and Acetaminophen Combo http://www.otcmarkets.com/stock/ELTP/news?id=204137

cctranscripts

today

Elite Pharmaceuticals Files Anda For Codeine And Acetaminophen Combo http://www.conferencecalltranscripts.org/pink/summary?id=5310939

cctranscripts

Sept. 6, 2018

Confidential treatment order http://www.conferencecalltranscripts.org/pink/summary?id=5277270

cctranscripts

Aug. 30, 2018

Financial Statements and http://www.conferencecalltranscripts.org/pink/summary?id=5257127

cctranscripts

Aug. 14, 2018

Elite Pharmaceuticals Reports Positive Topline Results From A Pivotal Bioequivalence Study http://www.conferencecalltranscripts.org/pink/summary?id=5200916

cctranscripts

Aug. 14, 2018

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study http://www.otcmarkets.com/stock/ELTP/news?id=200839

cctranscripts

Aug. 9, 2018

Elite Pharmaceuticals Inc. Just Filed Its Quarterly Report: NOTE 21. SUBSEQUENT ... http://www.conferencecalltranscripts.org/pink/summary?id=5184163

cctranscripts

Aug. 9, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information http://www.otcmarkets.com/stock/ELTP/news?id=200529

cctranscripts

Aug. 7, 2018

Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. To Its Board Of Directors http://www.conferencecalltranscripts.org/pink/summary?id=5172849

cctranscripts

Aug. 7, 2018

Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors http://www.otcmarkets.com/stock/ELTP/news?id=200065

cctranscripts

Aug. 7, 2018

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018 http://www.otcmarkets.com/stock/ELTP/news?id=200181

cctranscripts

Aug. 6, 2018

Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets http://www.otcmarkets.com/stock/ELTP/news?id=199968

cctranscripts

Aug. 6, 2018

Elite Pharmaceuticals Receives Fda Approval For Generic Methadone Hydrochloride Tablets http://www.conferencecalltranscripts.org/pink/summary?id=5168367

cctranscripts

July 19, 2018

Confidential treatment order http://www.conferencecalltranscripts.org/pink/summary?id=5119746

cctranscripts

July 10, 2018

Elite Pharmaceuticals Receives Fda Approval For Generic Percocet® Tablets http://www.conferencecalltranscripts.org/pink/summary?id=5093905

cctranscripts

July 3, 2018

Elite Pharmaceuticals Receives FDA Approval for Generic Percocet® Tablets http://www.otcmarkets.com/stock/ELTP/news?id=197064

cctranscripts

June 14, 2018

Elite Pharmaceuticals, Inc. Announces Passing Of Board Member Eugene Pfeifer http://www.conferencecalltranscripts.org/pink/summary?id=5025387

cctranscripts

June 14, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results For The Fiscal Year Ended March 31, 2018 And Provides Conference Call Information http://www.conferencecalltranscripts.org/pink/summary?id=5025746

cctranscripts

June 14, 2018

Elite Pharmaceuticals Inc. Just Filed Its Annual Report: NOTE 25. SUBSEQUENT... http://www.conferencecalltranscripts.org/pink/summary?id=5028289

cctranscripts

June 14, 2018

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer http://www.otcmarkets.com/stock/ELTP/news?id=195450
 


Feedback